600
Participants
Start Date
August 5, 2024
Primary Completion Date
August 31, 2028
Study Completion Date
August 31, 2028
Long-acting Cabotegravir injection
Cabotegravir is a potent integrase inhibitor that has been approved for use as PrEP.
SEARCH-YOUTH
It is a life stage informed HIV care model that dynamically supports adolescents and young adults living with HIV to achieve viral suppression and reduce depression through life event tailored solutions.
RECRUITING
MU-JHU Care Ltd, Kampala
Makerere University Joint AIDS Program
OTHER
Infectious Diseases Research Collaboration, Uganda
OTHER
Baylor College of Medicine
OTHER
University of California, San Francisco
OTHER
MU-JHU CARE
OTHER